13.35
+6.80%
Close of 9 Nov 2026, in INR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Nidan Laboratories and Healthcare
Its shares trade on NSE under the ticker NIDAN.NS. It has been listed since 12 November 2021. In the fiscal year to 31 March 2025, it reported revenue of ₹245.3m and net income of ₹19.8m. At that date it held total assets of ₹829.4m and shareholders' equity of ₹681.8m.
Nidan Laboratories & Healthcare Ltd. operates diagnostic imaging centers. The company is headquartered in Palghar, Maharashtra. The company went IPO on 2021-11-12. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to advanced radiology tests, including computerized tomography (CT) scans, magnetic resonance imaging (MRI) scans. The firm also offers a spectrum of customized health and wellness packages and value-added services to its customers, such as a home collection of specimens, house calls, and various delivery or access modes for test reports. The firm's tests area covers different age groups from offerings for prenatal screening to screening for hormonal imbalance, nutritional deficiencies and tracking lifestyle disorders.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 12 Nov 2021
- Website
- nidanhealthcare.co.in ↗
Leadership
Pay as last reported
- Dr. Nitin ThorveChief Executive Officer, since 2000
- Ms. Tejal JayakarChief Financial Officer, Executive Director, since 2018₹480,000
- Mr. Edwin DabreExecutive Director, since 2017₹420,000
- Mr. Krupesh ThakurNon-Executive Director
- Mr. Nilesh BideNon-Executive Independent Director
- Mr. Abhijeet DhanegaonkarNon-Executive Independent Director
- Mr. Karim KhimaniNon-Executive Independent Director
- Mr. Abhinay NerurkarNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Nidan Laboratories & Healthcare Ltd provides advanced diagnostic imaging services including CT and MRI scans.
- The company offers comprehensive pathology tests from basic biochemistry to high-end molecular diagnostics.
- Nidan's customized health packages cater to diverse age groups including prenatal and lifestyle disorder screening.
Weaknesses
- The company's diagnostic centers are limited to Palghar, Maharashtra, restricting broader market reach.
- Nidan's services are primarily focused on pathology and radiology without expanding into other medical sectors.
- The firm's home collection and house call services may face logistical challenges in rural areas.
Opportunities
- Expanding diagnostic services to other Indian cities like Mumbai and Pune could increase market share.
- Growing demand for molecular diagnostics in India presents a significant opportunity for Nidan.
- Increasing health awareness among Indian consumers drives demand for comprehensive health packages.
Threats
- Competition from established healthcare providers in Maharashtra poses a threat to market growth.
- Regulatory changes in India's healthcare sector could impact operational flexibility.
- Economic downturns may reduce consumer spending on non-essential health services.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.